Bristol-Myers, Avista Capital Partners, Nordic Capital A/S deal

Avista Capital and Nordic Capital completed their previously announced acquisition of Bristol-Myers’ ConvaTec wound care, ostomy care and skin care unit for $4.1 billion (see BioCentury, May 12). ...